Dose-Sparing Inactivated Polio Vaccine (IPV)

About AJ Vaccines

AJ Vaccines is a private, revenue-generating company founded in 2014 (operationally established in 2017) from the divestment of vaccine production at Denmark's Statens Serum Institut. It combines deep historical expertise in vaccine manufacturing with a modern, global outlook, employing over 500 people. Its core business involves the commercial production of vaccines, notably for polio, and the development of innovative solutions like dose-sparing technologies. The company is a key supplier to childhood vaccination programs and the WHO's Global Polio Eradication Initiative.

Therapeutic Areas

Other Polio Prevention Drugs